Post-COVID-19 cognitive impairment: a new target for drug development?
Drug Discovery World
APRIL 20, 2023
Dr Paula Moran, Dr Kiri Granger, Dr J Mark Treherne , and Dr Jenny Barnett explore the effects of long Covid-19 symptoms and what the opportunities are for drug developers working to treat post-Covid-19 cognitive impairment. New therapeutics of course depend on an understanding of biological mechanisms.
Let's personalize your content